VIA EXOSOMES Trademark

Trademark Overview

On Thursday, June 3, 2021, a trademark application was filed for VIA EXOSOMES with the United States Patent and Trademark Office. The USPTO has given the VIA EXOSOMES trademark a serial number of 90752435. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, April 4, 2024. This trademark is owned by Vivex Biologics Group, Inc.. The VIA EXOSOMES trademark is filed in the Pharmaceutical Products category with the following description:

Biological composition tissue intended for subsequent implantation
via exosomes

General Information

Serial Number90752435
Word MarkVIA EXOSOMES
Filing DateThursday, June 3, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, April 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 8, 2022

Trademark Statements

Goods and ServicesBiological composition tissue intended for subsequent implantation
Disclaimer with Predetermined Text"EXOSOMES"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVivex Biologics Group, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339
Party NameVivex Biologics Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339

Trademark Events

Event DateEvent Description
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 4, 2024SOU EXTENSION 4 GRANTED
Thursday, April 4, 2024SOU EXTENSION 4 FILED
Thursday, April 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 3, 2023SOU EXTENSION 3 GRANTED
Tuesday, October 3, 2023SOU EXTENSION 3 FILED
Tuesday, October 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 31, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 29, 2023SOU EXTENSION 2 GRANTED
Wednesday, March 29, 2023SOU EXTENSION 2 FILED
Wednesday, March 29, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 28, 2022SOU EXTENSION 1 GRANTED
Wednesday, September 28, 2022SOU EXTENSION 1 FILED
Wednesday, September 28, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, April 5, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 8, 2022PUBLISHED FOR OPPOSITION
Wednesday, January 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 4, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 4, 2022ASSIGNED TO LIE
Friday, December 31, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 31, 2021EXAMINER'S AMENDMENT ENTERED
Friday, December 31, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 31, 2021EXAMINERS AMENDMENT E-MAILED
Friday, December 31, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, December 31, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 31, 2021NON-FINAL ACTION E-MAILED
Friday, December 31, 2021NON-FINAL ACTION WRITTEN
Thursday, December 30, 2021ASSIGNED TO EXAMINER
Thursday, August 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 7, 2021NEW APPLICATION ENTERED

Related Keywords

exosomes subsequent implantation intended tissue composition biological